Searched for
ZYDUS THERAPEUTICS
Alkem rolls out single-shot semaglutide syringes at Rs 350 for diabetes, weight lossAlkem Laboratories has launched semaglutide in single-shot pre-filled syringes in India. This makes treatment more accessible and affordabl...02 Jun, 2026, 03.30 PM IST- Wockhardt secures US FDA approval for antibiotic ZaynichWockhardt's novel antibiotic, Zaynich (cefepime and zidebactam), has received US FDA approval for complicated urinary tract infections. Thi...30 May, 2026, 11.17 PM IST
- Stocks in news: RIL, Coal India, IDFC First Bank, Zydus Life, ONGCMarkets traded subdued with the India VIX correcting nearly 15% this week, though this hasn't significantly impacted benchmark index moveme...29 May, 2026, 06.01 AM IST
- Zydus Therapeutics' saroglitazar drug granted priority review by US FDAZydus Therapeutics' drug saroglitazar has received priority review from the US FDA. This drug treats primary biliary cholangitis, a liver d...28 May, 2026, 09.51 PM IST
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...24 May, 2026, 04.23 PM IST
- Zydus to buy Assertio for $166.4 millionZydus is acquiring US-based Assertio Holdings for $166.40 million to bolster its specialty oncology presence in the US. The deal, structure...14 May, 2026, 11.15 AM IST
- Zydus Lifesciences acquires US pharma firm Assertio for $166 millionIn a bold move that positions Zydus at the forefront of the U.S. specialty oncology market, the Indian drug manufacturer has secured a $166...14 May, 2026, 01.22 AM IST
- Zydus gets USFDA nod for generic drug to treat multiple sclerosisZydus Lifesciences has secured USFDA approval to market Glatiramer Acetate Injection, a generic version of Copaxone, for treating relapsing...09 May, 2025, 11.01 AM IST
- Zydus Lifesciences appoints Punit Patel as President & CEO, AmericasBefore joining Zydus, he was the President of Red Oak Sourcing, leading the company's "multibillion-dollar generic portfolio", overseeing a...16 Oct, 2023, 11.09 AM IST
- Zydus picks 6.5% in Mylab from Adar Poonawala co for ₹106 CrMylab came into limelight during Covid pandemic when it developed and launched indigenous RT-PCR test kits and platform for diagnosing Covi...26 Jun, 2023, 12.20 AM IST
- Zydus' US subsidiary acquires speciality drug asset in USUnder the terms of the agreement, Sentynl will acquire global rights to Nulibry and will be responsible for the ongoing development and com...08 Mar, 2022, 09.16 PM IST
- Zydus Cadila gets US Food and Drug Administration nod for diabetes medicationOn October 31, 2020, Zydus had filed a new drug application (NDA) with the USFDA seeking approval to market Sitagliptin base 25, 50 and 100...06 Sep, 2021, 01.09 PM IST
- PM's presence to motivate company in quest to bridge unmet healthcare needs: Zydus CadilaThe Zydus family comprising 25,000 Zydans stands committed to the 'Aatmanirbhar Bharat' mission and offering the nation safe and efficaciou...28 Nov, 2020, 03.56 PM IST
- Zydus Cadila acquires US-based Sentynl Therapeutics"It gains access to the specialty distribution network and a large prescriber base....This acquisition will also enable the Zydus group to ...19 Jan, 2017, 11.11 PM IST
- Zydus Cadila acquires six brands from Merck IndiaThe acquired brands Deca-Durabolin, Durabolin, Sustanon, Multiload, Sicastat and Axeten range had clocked sales of Rs 840 million in 2015.29 Dec, 2016, 12.03 AM IST
- Zydus eyes acquisitions to turn consumer arm into Rs 500-cr companyZydus Cadila Group, is looking for an exponential grown of its consumer product subsidiary, Zydus Wellness Ltd (ZWL).27 Aug, 2009, 01.31 PM IST
- Cadila buys out Liva in an all-cash dealZydus Group’s Cadila Healthcare has acquired Mumbai-based Liva Healthcare, a mid-sized Indian pharma company with a dermatology-focused pro...19 Mar, 2007, 12.52 AM IST
Load More
